Distribution incidence, mortality of tuberculosis and human development index in Iran: estimates from the global burden of disease study 2019

被引:2
|
作者
Fallahzadeh, Hossien [1 ,2 ]
Khazaei, Zaher [1 ,2 ]
Najafi, Moslem Lari [3 ]
Pordanjani, Sajjad Rahimi [4 ]
Goodarzi, Elham [5 ]
机构
[1] Shahid Sadoughi Univ Med Sci, Sch Publ Hlth, Ctr Healthcare Data Modeling, Dept Biostat, Yazd, Iran
[2] Shahid Sadoughi Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Yazd, Iran
[3] Kerman Univ Med Sci, Pharmaceut Sci & Cosmet Prod Res Ctr, Kerman, Iran
[4] Semnan Univ Med Sci, Social Determinants Hlth Res Ctr, Semnan, Iran
[5] Lorestan Univ Med Sci, Social Determinants Hlth Res Ctr, Khorramabad, Iran
关键词
Death; Incidence; Tuberculosis; HDI; Iran; EPIDEMIOLOGY; INEQUALITIES; RATES;
D O I
10.1186/s12889-023-17114-4
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Tuberculosis is one of the most serious challenges facing the global healthcare system. This study aims to investigate the incidence and mortality of tuberculosis in Iran from 2010 to 2019 as well as its relationship with the human development index (HDI).Methods The present study is an ecological study aiming at investigating the incidence and mortality of tuberculosis in Iran during the years 2010 to 2019. The related data were extracted from the Global Burden of Disease (GBD) website. The spatial pattern attributed to tuberculosis in the provinces of Iran was analyzed using ArcGIS software. In this study, the two-variable correlation method was used to analyze the data extracted to study the correlation between Tuberculosis and HDI.Result Based on the results recorded in GBD, the incidence of tuberculosis in 2010, that is, 14.61 (12.72, 16.74), declined compared to 2019, namely 12.29 (10.71, 14.09). The age-standardized mortality rate which was 1.63 (1.52, 1.73) in 2010, has decreased compared to 2019: 1.17 (1.07, 1.32). The incidence and mortality rates of tuberculosis in Iran in all age groups have decreased in 2019 compared to 2010. The highest incidence and mortality among tuberculosis patients were recorded in Sistan and Baluchistan and Golestan provinces. The results indicated that there was a negative and significant correlation between the mortality rate of tuberculosis and the human development index in 2010 (r = -0.509, P-value = 0.003) and 2019 (r = -0.36, P-value = 0.001); however, this correlation between incidence and human development index was not significant (p > 0.05).Conclusion Since mortality is mostly observed in areas with low HDI, health system policymakers must pay more attention to these areas in order to improve care and perform screenings to diagnose and treat patients thus reducing the mortality rate of tuberculosis and preventing an increase in its incidence in Iran.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Distribution incidence, mortality of tuberculosis and human development index in Iran: estimates from the global burden of disease study 2019
    Hossien Fallahzadeh
    Zaher Khazaei
    Moslem Lari Najafi
    Sajjad Rahimi Pordanjani
    Elham Goodarzi
    [J]. BMC Public Health, 23
  • [2] Correction: Distribution incidence, mortality of tuberculosis and human development index in Iran: estimates from the global burden of disease study 2019
    Hossien Fallahzadeh
    Zaher Khazaei
    Moslem Lari Najafi
    Sajjad Rahimi Pordanjani
    Elham Goodarzi
    [J]. BMC Public Health, 24
  • [3] Distribution incidence, mortality of tuberculosis and human development index in Iran: estimates from the global burden of disease study 2019 (vol 23, 2404, 2023)
    Fallahzadeh, Hossien
    Khazaei, Zaher
    Najafi, Moslem Lari
    Pordanjani, Sajjad Rahimi
    Goodarzi, Elham
    [J]. BMC PUBLIC HEALTH, 2024, 24 (01)
  • [4] The global burden of lymphoma: estimates from the Global Burden of Disease 2019 study
    Shen, Z.
    Tan, Z.
    Ge, L.
    Wang, Y.
    Xing, X.
    Sang, W.
    Cai, G.
    [J]. PUBLIC HEALTH, 2024, 226 : 199 - 206
  • [5] Estimates of incidence, prevalence, mortality, and disability-adjusted life years of lung cancer in Iran, 1990-2019: A systematic analysis from the global burden of disease study 2019
    Varniab, Zahra Shokri
    Tehrani, Yeganeh Sharifnejad
    Langroudi, Ashkan Pourabhari
    Azadnajafabad, Sina
    Rezaei, Negar
    Rashidi, Mohammad-Mahdi
    Esfahani, Zahra
    Malekpour, Mohammad-Reza
    Ghasemi, Erfan
    Ghamari, Azin
    Dilmaghani-Marand, Arezou
    Fateh, Sahar Mohammadi
    Shabestari, Alireza Namazi
    Larijani, Bagher
    Farzadfar, Farshad
    [J]. CANCER MEDICINE, 2022, 11 (23): : 4624 - 4640
  • [6] Global trends in the incidence rates of MDR and XDR tuberculosis: Findings from the global burden of disease study 2019
    Bu, Qingting
    Qiang, Rong
    Fang, Lingyan
    Peng, Xiaokang
    Zhang, Hua
    Cheng, Hua
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [7] Global and regional trends in the incidence and mortality burden of endometrial cancer, 1990–2019: Updated results from the Global Burden of Disease Study, 2019
    Feng Jianyang
    Lin Rongjin
    Li Haoxian
    Wang Jiayan
    He Hong
    [J]. 中华医学杂志(英文版), 2024, 137 (03)
  • [8] Association between Gastric Cancer Mortality-to-Incidence Ratio and Human Development Index: Evidence from the Global Burden of Disease Study 2016
    Nouri, Maryam
    Zayeri, Farid
    Akbari, Mohammad Esmaeil
    Khayamzadeh, Maryam
    Moradian, Farid
    [J]. ARCHIVES OF IRANIAN MEDICINE, 2021, 24 (12) : 869 - 875
  • [9] The global burden and temporal trend of cancer attributable to high body mass index: Estimates from the Global Burden of Disease Study 2019
    Zhi, Xing
    Kuang, Xiao-Hong
    Liu, Kuan
    Li, Jian
    [J]. FRONTIERS IN NUTRITION, 2022, 9
  • [10] Burden of prostate cancer and relationship with the human development index (HDI) in Asia: A study of Global Burden disease in 2019
    Fathollahi, Fazlollah
    Khazaei, Zaher
    Abbasi, Mahshid
    Goodarzi, Elham
    [J]. CASPIAN JOURNAL OF INTERNAL MEDICINE, 2023, 14 (04) : 710 - 719